Patent · US Active

Subcutaneous paliperidone composition

US8758780B2 · kind B2 · utility

0Cited by

4References

14Claims

0Family size

Assignee

ASCENDIS PHARMA A/S · DK

Inventors

Kennett Sprogøe · Rudegård, DK
Ulrich Hersel · Heidelberg, DE
Harald Rau · Würzburg, DE
Guillaume Maitro · Mannheim, DE
Thomas Wegge · Heidelberg, DE

Key dates

Filing date	Oct 6, 2010
Grant date	Jun 24, 2014
Priority date	—
Expiry date	Oct 6, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/24
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pharmaceutical composition for subcutaneous injection comprising a paliperidone compound wherein the composition releases the paliperidone with an immediate onset of action and continuously for at least 3 weeks, and wherein the composition has a pharmacokinetic profile in vivo with substantially no burst release of the paliperidone. The compositions are useful as medicaments for the treatment of psychotic disorders and diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.